TCT 2025 | INVEST-CTO: Effectiveness and Safety of a Planned Investment Procedure in High-Risk CTO PCI

The success rate of percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) remains lower than for non-occlusive lesions, especially in complex CTOs. Furthermore, complications increase in prolonged and unsuccessful procedures, leading many CTO patients to be less frequently offered percutaneous revascularization.

When the initial attempt fails, a balloon dilation aimed at modifying the CTO is often performed, a strategy that has retrospectively shown to improve success rates in subsequent procedures.

The aim of the INVEST-CTO study was to determine whether, in patients with highly complex anatomical CTOs, a planned two-stage strategy—initial modification followed by a second procedure for complete recanalization—results in higher procedural success and improved safety.

The primary endpoint (PEP) was procedural success, defined as technical success without major adverse cardiac events (MACE: death, myocardial infarction, or clinically driven revascularization of the treated vessel). The secondary endpoint (SEP) was a 30-day safety composite.

Read also: TCT 2025 | INFINITY–SWEDEHEART: Long-Term Outcomes of the Bioadaptive Coronary Implant Versus Drug-Eluting Stent.

A total of 153 patients were analyzed, with a mean age of 66 years, predominantly male. The most common presentation was stable coronary artery disease. The mean J-CTO score was 4, indicating high complexity. The right coronary artery was most frequently involved (66%), followed by the left anterior descending (16%) and the circumflex (16%).

Regarding the PEP, the procedural success rate was 86.7% (95% CI 80.3–91.7; p < 0.05). For the SEP, the 30-day composite adverse event rate was 4.6%, suggesting a favorable safety profile.

Conclusion

A planned two-stage strategy for complex CTO intervention proved safe and effective. Initial modification of the CTO should be considered an early and rational approach in high-risk CTOs, with the potential to increase success rates and reduce complications.

Reference: Anja Øksnes, MD. TCT 2025.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Andrés Rodríguez
Dr. Andrés Rodríguez
Member of the Editorial Board of solaci.org

More articles by this author

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically as ischemia, myocardial infarction,...

OCT-Detected High-Risk Plaques Predict Recurrent Events After Myocardial Infarction

After a myocardial infarction (MI), non-culprit lesions are often deferred when they are not flow-limiting (negative FFR). However, these lesions continue to represent an...

Ticagrelor vs Clopidogrel in ACS Patients Receiving DOAC After PCI: More Bleeding Without Ischemic Benefit?

In patients with acute coronary syndrome (ACS) who require direct oral anticoagulation (DOAC) and undergo percutaneous coronary intervention (PCI), current guidelines recommend a dual...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

SAPIEN 3 TAVI Durability: Ten-Year Follow-Up in Intermediate-Risk Patients

The durability of transcatheter bioprosthetic valves used in TAVI remains one of the key unanswered questions as indications continue to expand toward patients with...

Aneurysm Sac Regression Predicts Better Clinical Outcomes After EVAR?

Aneurysm sac regression following endovascular abdominal aortic aneurysm repair (EVAR) has been proposed as a marker of favorable remodeling and effective aneurysm exclusion. However,...

Inflammation after TAVI: An Emerging Therapeutic Target?

Conduction disturbances and the need for permanent pacemaker implantation remain common complications following TAVI, with an incidence approaching 15%. Although they have traditionally been...